Introduction {#s1}
============

Bronchoscopy is an invaluable procedure for many specialities, including anaesthesiology \[[@C1]\], intensive care \[[@C2], [@C3]\], respiratory medicine \[[@C4]\] and thoracic surgery \[[@C5], [@C6]\]. The learning curve for the acquisition of bronchoscopy skills, however, is steep and very individual \[[@C7]\].

A case should be made for mandatory teaching on a simulator for would-be bronchoscopists \[[@C8], [@C9]\]. Employment of trainees in the operating room has been shown to add to the duration of the procedure by an average of 18 min with a potential for up to three-fold increased risk of complications for the patient \[[@C10]\]. Moreover, as much as a five-fold increase in the costs of repairs to bronchoscopes has been reported \[[@C11]\]. With an average of 3.5 weeks for repairs \[[@C12]\], this has serious implications for a bronchoscopy service. This has been addressed with an education programme employing a simulator \[[@C13]\].

Simulation has been shown to improve trainees\' performance in the operating room \[[@C14]--[@C17]\]. A systematic review of 30 publications on flexible bronchoscopy and endobronchial ultrasound showed simulation-based training to be more efficient than the traditional apprenticeship model for trainees at the start of their career, and advised this should be compulsory \[[@C18]\]. Furthermore, a training programme incorporating self-directed learning and using a combination of physical and virtual reality simulators was recommended \[[@C18]\].

There are a number of simulators currently available that are reported to deliver anatomically authentic reconstructions of the airway tree \[[@C19]\] but lack realistic tactile feedback of respiration and instrument/airway interaction \[[@C8]\]. Expense tends to restrict the higher fidelity models to central teaching hospitals \[[@C8]\].

We have developed a low-cost, easy-to-use bronchoscopy biosimulator utilising re-useable, inflatable, BioFlex-preserved porcine lungs. The objective of this study was to evaluate its acceptability as a training aid for diagnostic procedures (inspection, endobronchial brush and biopsy) and for therapeutic interventions (foreign body retrieval and endobronchial valve implantation) in the lower airways, and facilitate more widespread availability.

Materials and methods {#s2}
=====================

The device {#s2a}
----------

The bronchoscopy biosimulator was conceived by J.L. Garner, and developed in collaboration with S.D. Garner and R.J. Hardie. BioQuest porcine lungs (Medisave UK Ltd, Weymouth, UK) housed hygienically in a clear acrylic box, supported if necessary, for smaller lungs by a removable platform, were connected to a bulkhead coupling (a tube passing through the front of the box). Hand-operated bellows were linked to the coupling *via* a conventional double-swivel elbow connector with bronchoscopy port and a shortened, size 9.0, uncuffed endotracheal tube that was push-fitted into the external, chamfered orifice of the coupling to create a closed ventilator system ([figure 1](#F1){ref-type="fig"}).

![The bronchoscopy biosimulator and Ambu aScope 4 Broncho Large connected to aView monitor.](00035-2019.01){#F1}

When not in use, the lungs were stored in a sandwich box (dimensions 220×160×80 mm), immersed in BioFlex solution, a patented humectant fluid (25% propylene glycol and 75% water) that prevents tissue desiccation, inhibits bacterial growth, is nontoxic and is biodegradable. The box and fittings, which can be dismantled if necessary, were cleaned with Clinell Universal Wipes (GAMA Healthcare, Watford, UK).

The simulation session {#s2b}
----------------------

Two groups of bronchoscopists, experienced (n=11) and trainee (n=15), were invited to attend a simulation session using the bronchoscopy biosimulator and the AccuTouch bronchoscopy simulator by CAE Healthcare (Oxford, UK). Experienced bronchoscopists were defined as those with ≥4 years of procedural exposure and trainee bronchoscopists as those with ≤1 year of exposure.

Inspection of the airways, endobronchial brushing and endobronchial biopsy were practised on both devices. Foreign body retrieval and endobronchial valve implantation, not options on our AccuTouch, were also performed on the bronchoscopy biosimulator.

The evaluation {#s2c}
--------------

Attendees were asked to complete a questionnaire reflecting their opinions on the capabilities and realism of both simulators using a seven-item, five-point Likert scale ([figure 2](#F2){ref-type="fig"}) adapted from that used by G[oldberg]{.smallcaps} *et al.* \[[@C20]\]. As this was used as a service evaluation tool, no ethical approval was required.

![Questionnaire using a seven-item, five-point Likert scale to evaluate the bronchoscopy biosimulator.](00035-2019.02){#F2}

Statistical analysis {#s2d}
--------------------

Data are presented as median (interquartile range) and mean±[sd]{.smallcaps}. Comparisons between experienced and trainee groups were evaluated using the Mann--Whitney U-test. Statistical analysis was performed using SPSS version 24.0 (IBM, Chicago, IL, USA). Differences were considered to be statistically significant when the p-value was \<0.05.

Results {#s3}
=======

26 bronchoscopists, 11 experienced and 15 trainees, took part in this service evaluation. Both groups were positive about their simulation encounter (mean score of 4.76) ([figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"} and [tables S1 and S2](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00035-2019.figures-only#fig-data-supplementary-materials)). The bronchoscopy biosimulator was found to be helpful in learning to perform a variety of diagnostic and therapeutic procedures (mean score of 4.85), interacting with an assistant (mean score of 4.85) and demonstration of safety issues (mean score of 4.70). Importantly, the bronchoscopy biosimulator compared favourably to the computer simulator (mean score of 4.84), improved operator confidence (mean score of 4.47), was realistic (mean score of 4.64) and easy to use (mean score of 4.88).

![Experienced bronchoscopists\' feedback. a) Item 1: learning how to perform. b) Item 2: interaction with assistant. c) Item 3: demonstration of safety issues. d) Item 4: comparison to AccuTouch. e) Item 5: confidence. f) Items 6 and 7: realism and ease of use.](00035-2019.03){#F3}

![Trainee bronchoscopists\' feedback. a) Item 1: learning how to perform. b) Item 2: interaction with assistant. c) Item 3: demonstration of safety issues. d) Item 4: comparison to AccuTouch. e) Item 5: confidence. f) Items 6 and 7: realism and ease of use.](00035-2019.04){#F4}

Statistically significant differences were observed between experienced and trainee bronchoscopists, respectively, in their feedback on: 1) assistant interaction when performing airway inspection (mean scores of 4.55 *versus* 4.87; p=0.037) and valve implantation (mean scores of 4.60 *versus* 4.93; p=0.046); 2) safety when performing airway inspection (mean scores of 4.45 *versus* 4.87; p=0.034) and foreign body retrieval (mean scores of 4.45 *versus* 4.87; p=0.034); and 3) confidence in performing airway inspection (mean scores of 3.82 *versus* 4.87; p=0.005) and endobronchial brushing (mean scores of 4.00 *versus* 4.86; p=0.024).

Discussion {#s4}
==========

Although an established aid, choice of bronchoscopic simulators is limited. Realism and cost are issues \[[@C8]\]: the bronchoscopy biosimulator addresses these problems. The model employs a hand-ventilated porcine lung to represent an intubated and ventilated patient. The bronchial anatomy is of course not identical to that of the human lung and it is not intended for teaching this aspect \[[@C21]\]. However, the appearance of the airways, the elasticity of the lung, and its responses to inflation and deflation are, to judge from experienced feedback, indistinguishable. The tactile feedback is unmatched by synthetic simulators.

The porcine lungs preserved in BioFlex solution are obtained from BioQuest, who also supply the bellows, and advice on maintenance and storage. It has proven robust in use for up to 12 months. Air leaks, after biopsy, can be managed with prolene suture or staple. Irreparably damaged lungs are easily replaced at a low cost of approximately GBP 88 (USD 115).

The bronchoscopy biosimulator is compact, lightweight and portable, and is quickly and easily set up. The orientation of its mount is adjustable. Cleaning and storage, as instructed, are simple, but important to ensure its reusability. In use, the lungs are in a sealed container and the ventilation system is closed: aerosolisation is unlikely.

A bronchoscope dedicated for use only with this simulator is recommended. The aScope 4 (Ambu, Copenhagen, Denmark) series of bronchoscope with its monitor is inexpensive \[[@C22]\], produces good imaging, is robust \[[@C23]\] and is, for this purpose, re-usable.

Our results show that trainee and established bronchoscopists find the bronchoscopy biosimulator beneficial for learning diagnostic and therapeutic procedures in the lower airways, improves operator confidence and assistant interaction, is realistic, and is easy to use.

The cost estimated to build the bronchoscopy biosimulator is GBP 1500 (USD 1970). Low-fidelity products, for example, Nakhosteen\'s Broncho Boy and AirSim Bronchi (TruCorp Ltd, Belfast, UK) are marketed at GBP 3073 (USD 4033) and GBP 3551 (USD 4660), respectively; CAE EndoVR (successor to the AccuTouch) is GBP 80 000 and other high-fidelity simulators cost approximately GBP 33 000--80 000.

Conclusions {#s4a}
-----------

Bronchoscopy is a valued tool that is increasingly in demand for the assessment and treatment of respiratory disorders. However, its safe and effective deployment demands a high degree of skill in its operators, acquired through experience and practice.

The bronchoscopy biosimulator, a supplement to patient contact, contributes to the opportunities to develop skills in an environment that is realistic, is free of patient safety issues and time constraints, and provides a complementary training tool to commercially available simulation models.
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Bronchoscopy BioSim used with an Olympus flexible bronchoscope demonstrating airway inspection, endobronchial brushing, endobronchial biopsy, foreign body retrieval, and endobronchial valve implantation. 00035-2019.video1

Bronchoscopy BioSim used with an Ambu aScope 4 bronchoscope connected to aView monitor demonstrating endobronchial appearances during manual ventilation of the porcine lung. 00035-2019.video2
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